23 results
Pharmacologic prophylaxis of VTE in selected clinical scenarios.

Enoxaparin 
Dalteparin 
Fondaparinux 
Dabigatran 
Unfractionated Heparin
Warfarin 
Aspirin 

#prophylaxis #VTE
VTE in selected clinical ... prophylaxis #VTE #DVT #dosing ... #Medications #management ... #indications #pharmacology ... #table
REBEL Review 4 & 5: Paralytic & Vasopressor Dosing 

Paralytic Agents:
 - Succinylcholine (Depolarizing Agent)
& Vasopressor Dosing ... resuscitation #table ... #criticalcare # ... pharmacology #dosing ... #medications #Comparison
SGLT2 Inhibitors 
SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
anti-diabetic medications ... kidney), which causes ... glucose in the urine ... SGLT2 #Inhibitors #Pharmacology ... #Diabetes #Endocrinology
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Type 2 Inpatient Medication ... Guide Classes ... #pharmacology # ... comparison #table ... #endocrinology
Review of Intranasally Administered Medications for Use in the Emergency Department
Table of agents, uses, dosing, onset
Emergency Department Table ... of agents, uses ... , dosing, onset ... #Comparison #Table ... #Pharmacology #
Potassium-Binding Agents to Treat Hyperkalemia
Sodium zirconium cyclosilicate (Lokelma):
 • Mechanism: Preferentially captures K in exchange for
and sodium • Dosing ... and calcium • Dosing ... #Hyperkalemia #medications ... #pharmacology # ... table #comparison
Intern Pocket Cards - Inpatient Bowel Regimen Guide
Osmotic agents (draws water into bowel, thereby loosening stool
Polyethylene glycol - Nausea ... enema - Discomfort during ... Guide #Inpatient #medications ... #constipation #pharmacology ... #table #agents
21-Hydroxylase Deficiency (21-OHD): Pathogenesis and Clinical Findings
Autosomal recessive mutation in CYP21A2 coding for the enzyme 21-OHase
Pathogenesis and Clinical ... mutation in CYP21A2 coding ... enzyme 21-OHase causes ... non-arousable, decr urine ... pathophysiology #genetics #endocrinology
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Eosinophils < 100 Dosing ... : 250 mcg tablet ... the use of this medication ... won’t have any clinical ... #Pharmacology #
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
GLP-1 Agonist Dosing ... semaglutide, the same medication ... drug to remain stable ... semaglutide #Diabetes #Pharmacology ... #Endocrinology